Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage.
Heart
Hypertension
Inflammation
Kidney
Microbiome
Journal
Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427
Informations de publication
Date de publication:
13 06 2023
13 06 2023
Historique:
received:
23
09
2021
revised:
04
07
2022
medline:
14
6
2023
pubmed:
30
7
2022
entrez:
29
7
2022
Statut:
ppublish
Résumé
Hypertension (HTN) can lead to heart and kidney damage. The gut microbiota has been linked to HTN, although it is difficult to estimate its significance due to the variety of other features known to influence HTN. In the present study, we used germ-free (GF) and colonized (COL) littermate mice to quantify the impact of microbial colonization on organ damage in HTN. 4-week-old male GF C57BL/6J littermates were randomized to remain GF or receive microbial colonization. HTN was induced by subcutaneous infusion with angiotensin (Ang) II (1.44 mg/kg/day) and 1% NaCl in the drinking water; sham-treated mice served as control. Renal damage was exacerbated in GF mice, whereas cardiac damage was more comparable between COL and GF, suggesting that the kidney is more sensitive to microbial influence. Multivariate analysis revealed a larger effect of HTN in GF mice. Serum metabolomics demonstrated that the colonization status influences circulating metabolites relevant to HTN. Importantly, GF mice were deficient in anti-inflammatory faecal short-chain fatty acids (SCFA). Flow cytometry showed that the microbiome has an impact on the induction of anti-hypertensive myeloid-derived suppressor cells and pro-inflammatory Th17 cells in HTN. In vitro inducibility of Th17 cells was significantly higher for cells isolated from GF than conventionally raised mice. The microbial colonization status of mice had potent effects on their phenotypic response to a hypertensive stimulus, and the kidney is a highly microbiota-susceptible target organ in HTN. The magnitude of the pathogenic response in GF mice underscores the role of the microbiome in mediating inflammation in HTN.
Identifiants
pubmed: 35904261
pii: 6651675
doi: 10.1093/cvr/cvac121
pmc: PMC10262185
doi:
Types de publication
Journal Article
Randomized Controlled Trial, Veterinary
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1441-1452Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.
Déclaration de conflit d'intérêts
Conflict of interest: none declared.
Références
Nature. 2017 Nov 30;551(7682):585-589
pubmed: 29143823
Cell. 2020 Mar 19;180(6):1067-1080.e16
pubmed: 32160527
Scand J Immunol. 2017 Apr;85(4):258-263
pubmed: 27943364
Hypertension. 2015 Jun;65(6):1331-40
pubmed: 25870193
Circulation. 2020 Apr 28;141(17):1393-1403
pubmed: 32093510
Microbiome. 2017 Feb 1;5(1):14
pubmed: 28143587
Circ Res. 2021 Apr 2;128(7):934-950
pubmed: 33793332
Arthritis Rheumatol. 2014 Mar;66(3):731-9
pubmed: 24574234
Vascul Pharmacol. 2020 Feb - Mar;125-126:106633
pubmed: 31843471
J Am Heart Assoc. 2016 Aug 30;5(9):
pubmed: 27577581
Circ Res. 2021 Apr 2;128(7):908-933
pubmed: 33793336
Circulation. 2019 Mar 12;139(11):1407-1421
pubmed: 30586752
Arthritis Rheumatol. 2016 Sep;68(9):2200-9
pubmed: 27111767
Hypertension. 2012 Dec;60(6):1430-6
pubmed: 23108651
Hypertension. 2010 Feb;55(2):500-7
pubmed: 20038749
J Nutr. 1986 Sep;116(9):1772-6
pubmed: 3761032
Adv Immunol. 2014;121:91-119
pubmed: 24388214
Sci Rep. 2018 Jun 5;8(1):8598
pubmed: 29872089
Am J Physiol Renal Physiol. 2009 Nov;297(5):F1457-65
pubmed: 19675178
N Engl J Med. 2013 Sep 5;369(10):954-64
pubmed: 24004122
Semin Immunol. 2007 Apr;19(2):59-69
pubmed: 17118672
Cardiovasc Res. 2020 Apr 1;116(5):1059-1070
pubmed: 31241148
Physiol Genomics. 2017 Feb 1;49(2):96-104
pubmed: 28011881
J Am Soc Nephrol. 2015 Aug;26(8):1877-88
pubmed: 25589612
Circ Res. 2015 Oct 23;117(10):858-69
pubmed: 26294657
Sci Immunol. 2020 Aug 7;5(50):
pubmed: 32769171
Kidney Int. 2012 Feb;81(4):379-90
pubmed: 21975862
Hypertension. 2019 Jul;74(1):184-193
pubmed: 31154901
J Am Soc Nephrol. 2017 May;28(5):1450-1461
pubmed: 27927779
Physiology (Bethesda). 2020 Jul 1;35(4):275-284
pubmed: 32490748
Kidney Int. 2006 Apr;69(7):1189-97
pubmed: 16609683
J Biol Chem. 2010 Sep 3;285(36):27601-8
pubmed: 20601425
Am J Hypertens. 2001 May;14(5 Pt 1):405-8
pubmed: 11368457
Circ Res. 2017 Jan 20;120(2):312-323
pubmed: 27799253
Eur J Immunol. 2004 Nov;34(11):3246-56
pubmed: 15376194
Toxins (Basel). 2020 Aug 26;12(9):
pubmed: 32859011
Cell. 2016 Mar 24;165(1):111-124
pubmed: 26972052
J Am Heart Assoc. 2017 Jun 29;6(7):
pubmed: 28663251
Hypertension. 2020 Dec;76(6):1847-1855
pubmed: 33070663
Eur Heart J. 2020 Nov 21;41(44):4259-4267
pubmed: 32869053
Circulation. 2019 Jan 2;139(1):78-96
pubmed: 30586693
Kidney Int. 2017 Sep;92(3):634-645
pubmed: 28396122
Mol Immunol. 2019 Jan;105:107-115
pubmed: 30502718
Sci Rep. 2019 Apr 10;9(1):5844
pubmed: 30971724
Immunity. 2015 Oct 20;43(4):817-29
pubmed: 26488817
Sci Transl Med. 2017 Feb 22;9(378):
pubmed: 28228602
Kidney Int. 2010 Dec;78(11):1136-53
pubmed: 20736988
Circulation. 2017 Mar 7;135(10):964-977
pubmed: 27927713
Cell. 2009 Oct 30;139(3):485-98
pubmed: 19836068